Background: Indians are genetically predisposed to Coronary Artery Disease (CAD), hence it is worth studying the effect of genetic polymorphisms which affect CAD development including Low-Density Lipoprotein Cholesterol (LDL-C) in our population. Studies have found that there is a considerable variation in the genetic makeup of Indians with distinct genetic groups hav ing been identified-one such being Dravidian Tamil population. Aim:We aimed to determine the distribution of allele and genotype frequencies of genes associated with LDL-C lipid levels as well as those associated with statin metabolic pathway in 100 healthy South Indian Tamil volunteers. Results:The minor allele frequencies (MAFs) of the genetic polymorphisms of HMGCR rs5908, rs17238540 and rs12916 were 0.5, 3.5 and 41% respectively. The MAF of LDLR rs688, CYP7A1 rs3808607, ABCB1 rs1128503, SLCO1B1 rs4149056 were 26, 42, 41.5 and 7% respectively. The frequencies of the genetic polymorphisms studied show considerable variation from other Indian ethnic groups in 5 out of the 7 genetic poly-
INTRODUCTION
Elevated levels of Low-Density Lipoprotein Cholesterol (LDL-C) is associated with an increased risk of coronary artery disease (CAD).
1 LDL-C levels are affected by genetic and environmental factors. The basal risk in the form of genetic variations is not modifiable, although they are to a good extent modulated by environmental factors. Exploring and characterizing these genetic variations for each population would provide the background information needed to conduct further studies on lipid abnormalities and their treatment. Lipid traits are up to 60% heritable. 2 Indians being predisposed to CAD, 3 it is essential to study the genetics of LDL-C to help predict CAD and to implement preventive measures in this high-risk population. Till now, 157 gene loci have been studied for association with blood lipid levels which could explain only 12-14% variation in the lipid levels. 4 The clinical significance of genetic variants associated with lipid abnormalities depends on the frequency of genetic variants in the population of interest. Further, the normative data of frequency of single nucleotide polymorphism (SNP) is essential for planning and conducting genotypephenotype association studies. The frequency distribution of SNPs in other population cannot be used for planning studies in Indian population due to their unique genetic constitution. 5 In earlier studies, the frequencies of genetic polymorphisms of genes involved in lipid and statin pathways such as ApoA, ApoB, 6 CETP, 7 ABCB1, 8, 9 and CYP3A5 10 have been established among healthy South Indian Tamil population in our laboratory. For the current study, SNPs were selected based on their role in statin and cholesterol metabolism. These variants have been associated with altered LDL-C response to statins or associated with toxicity in other populations. However, there is no data among South Indian Tamil patients. Genes such as HMGCR, LDLR and CYP7A1 are involved in the cholesterol metabolic pathway. HMGCR codes for 3-hydroxy-3-methylglutaryl-CoA reductase which is the rate-limiting enzyme for cholesterol synthesis.
11 LDLR codes for low -density lipoprotein receptor, which is involved in endocytosis of LDL cholesterol.
12 CYP7A1 belongs to Cytochrome 450 group of enzymes which catalyzes the rate limiting step in cholesterol catabolism to bile acids, the major route of cholesterol elimination from the body.
13 ABCB1 encodes the membrane associated protein which is a member of the superfamily of ATP-binding cassette (ABC) transporters which is involved in efflux of statins.
14 The SLCO1B1 codes for hepatic solute carrier organic anion transporter family member 1B1 which is responsible for uptake of bilirubin and its metabolites and drugs like statins. 15 Hence in the current study, we aimed to determine the frequencies of genetic variations for other genes in the lipid pathway such as HMGCR (rs5908, rs17238540, rs12916), LDLR (rs688), CYP7A1 (rs3808607), ABCB1 (rs1128503), and SLCO1B1 (rs4149056) in South Indian Tamil population. We also aimed to compare the studied genotype distributions with that of other ethnic populations.
MATERIALS AND METHODS
The study was approved by the Institute Ethics Committee (Human Studies) of Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India. Written informed consent was obtained from participants recruited for the study. The study was conducted among 100 apparently healthy volunteers of either gender, aged between 27 and 70 years. All study subjects belonged to South Indian Tamil ethnicity which was defined as people with history of their past three generations residing in the state of Tamil Nadu or Puducherry and speaking Tamil language as the mother tongue. Five milliliters of blood for genotyping was collected from the forearm of the patient in sitting posture, using ethylenediamine tetra-acetic acid (EDTA) as the anticoagulant. The cellular layer including the buffy coat was separated using ultracentrifugation at 2500 rotations per minute (RPM) for 10 min, and stored at -20 0 C, until extraction. DNA extraction was performed using standard phenol chloroform method. Genotyping was done with allelic discrimination assays, with the kits obtained from Applied BioSystems (ABI) USA. The assay kits were based on TaqMan Technology. Real-Time PCR platform ABI 7300 was used. The allelic call was read with the help of sequence manipulation suite (SMS) version 1.4. The genotyping results were confirmed by running the samples in triplicates (representative genotypes) and by Sanger sequencing. Hardy-Weinberg equilibrium for the studied genotypes was tested using Chi-square test. Genotype frequencies from the current study were compared with data from other studies using Fisher's Exact Test or Chisquare test. P value less than 0.05 was considered significant. All statistical tests were done using GraphPad Instat v 3.0 (GraphPad Software Inc., San Diego, CA, USA).
RESULTS
The study subjects included 75 females and 25 males with a mean age of 45.5 ± 10.9 (SD). The genotype and allele frequencies established in this study are given in Table 1 . HMGCR rs5908 was found to be very rare in the study population with only one subject having a heterozygous variant genotype with the absence of homozygous variant genotype. HMGCR rs17238540 polymorphism was also less prevalent in our population with the frequency of 3.5%.The variant alleles of HMGCR rs12916, CY-P7A1 rs3808607 and ABCB1 rs1128503 polymorphisms were found to be more prevalent. The variant genotype of SLCO1B1 rs4149056 polymorphism was not found in our population. All genotypes except LDLR rs688 polymorphism did not show significant deviation from Hardy -Weinberg equilibrium.
Data of genotype and allele counts of the studied SNPs from North India 16 and other major ethnic groups retrieved from 1000 genomes project phase 3 population 17 are given in Table 2 . The distribution of variant genotypes of HMGCR rs5908 observed in our population was significantly different only from North Indian population. However, distribution of HMGCR rs17238540 genotypes were significantly different from other populations except for CEU (Utah residents with Northern and Western European Ancestry), MXL (Mexican Ancestry in Los-Angeles, California), and Europeans from Norfolk-United Kingdom. 18 The distribution of HMGCR rs12916 genotypes was significantly different from that of CEU, YRI (Yoruba in Ibadan, Nigeria) and MXL population. The distribution of LDLR rs688 genotypes in the current study was distinctly different from the other populations except that of CHB (Han Chinese in Beijing, China). The distribution of genotypes of CYP7A1 rs3808607 polymorphism was significantly different from a north Indian study which included patients from Punjab, Haryana and Chandigarh and also from YRI and JPT (Japanese in Tokyo, Japan)but not from other population of North India. 19 The distribution of ABCB1 rs1128503 was significantly different from that of CEU and YRI population. The distribution of genotypes of SLCO1B1 in our population was significantly different from that of GIH (Gujarati Indian in Houston), CEU, CHB, and YRI. 
DISCUSSION
The present study has determined the normative data on allele and genotype frequencies for SNPs of five genes namely, HMGCR (rs5908, rs17238540, rs12916), LDLR (rs688), CYP7A1 (rs3808607), ABCB1 (rs1128503), and SLCO1B1 (rs4149056). These genes are involved in the maintenance of plasma lipid levels and the metabolism of statin drugs.
To the best of our knowledge this study is the first to describe this information for South Indian Tamil population. The normative data on allele and genotype frequencies are important for planning of any genetic study to estimate sample size and to understand the clinical implications of a genetic variation. Thus, the current study provides the background information needed for future studies on pharmacogenetics of lipid metabolism and statins among South Indian Tamil population. Genetic variants of HMG-CoA reductase (HMGCR) have been widely studied for their effect on lipid levels and variations in therapeutic responses to different statins. HMGCR variants have been associated with diminished response to pravastatin and simvastatin but not to fluvastatin 20 and atorvastatin. 21 Further, they were also found to be associated with varied response between different ethnic groups. 22 Among the three SNPs studied in HMGCR gene, variant genotypes of rs12916 and rs17238540 are more common in the study population. In contrast, HMGCR rs5908 variant being in low frequency may have less clinical relevance for the study population, even if functionally significant. Functional studies on rs12916 and rs17238540 variants may have clinical relevance in elucidating the effect of these SNPs on lipid homeostasis. The HMGCR rs17238540 was found to be associated with reduced efficacy of statins in terms of lowering plasma levels of total cholesterol (TC) and LDL-C. Individuals with heterozygous variant genotype (GT) had 19% lower reduction in LDL-C when treated with pravastatin. 23 In the GoDARTS study, individuals with HMGCR rs17238540 variant G allele were associated with failure to achieve lipid lowering target. 24 In a study by Poduri et al., in North Indian population, the variant genotypes of HMGCR rs17238540 was associated with significantly higher LDL-C levels after atorvastatin therapy compared to wild type. 25 However, in a study by Thompson et al. , this SNP was not associated with response to atorvastatin. 21 In few studies, HMGCR rs17238540 was not associated with baseline lipid values. 18, 23, 24 In the multi-ethnic study of atherosclerosis the HMGCR haplotypes, 26 and these genotypes among North Indians were associated with baseline lipid levels respectively. 25 It was also observed that the HMGCR rs17238540 might negate some of the observed pleiotropic effects of statins, such as improved endothelial function, decreased platelet aggregability and reduced vascular inflammation and was also found to be associated with stroke risk in the EPICNorfolk study. 27 The HMGCR rs12916 locus has been associated with total cholesterol and LDL-C levels among Europeans as well as East Asians and South Asians in a genome wide study. 28 In candidate gene studies the mean percentage reduction in LDL-C with HMGCR rs12916 polymorphisms among Chinese were found to be highest for homozygous variant, least for wild genotype and intermediate for heterozygous individuals after treatment with statins 29 while, studies among North Indians revealed that variant genotypes of this polymorphisms were responsible for poor response to atorvastatin in terms of LDL-C lowering. 25 Given the high prevalence of this genetic polymorphism among Tamilians, it would be of interest to determine the effect of this polymorphism on the lipid levels in our population. LDL receptor gene (LDLR) is a commonly studied genetic locus for dyslipidemias. Genetic variations in LDL receptor gene may greatly reduce or abolish the function of LDL receptor. This may lead to increase in circulating LDL-C levels and risk of CAD. 30 Although LDLR gene mutations are associated with familial hypercholesterolemia (FH), less dysfunctional variants have been associated with response to statin in non -FH individuals. 31 Studies by Haiyan Zhu and his colleagues have identified SNP LDLR rs688 to be present in 60% of Caucasians and associated with a significant 10% increase in total and LDL-cholesterol in pre-menopausal women. 32 This SNP has been recently shown to alter splicing efficiency, with the T allele being associated with increased total and LDL-cholesterol levels among premenopausal women. 33 Since this SNP is present in high frequency in the study population, and since it has not been studied among Indian population at large, more studies on the functional significance, of this SNP might yield useful information on the genetics of LDL-C in our population. The genotype distribution of CYP7A1 rs3808607 variants among Tamilian population was found to be similar to another study involving people from Lucknow region of North India, 19 whereas it was significantly different from the results obtained in a study among North Indian regions of Punjab, Haryana, and Chandigarh, 16 revealing the diversity even among North Indians. The genetic variants of CYP7A1 rs3808607, ABCB1 rs1128503, and SLCO1B1 rs4149056, although similar to most other populations in frequency distribution, were found to occur at a higher frequency in the study population and may have clinical relevance if functional significance can be demonstrated in future studies.
CONCLUSION
The study has established the allele and genotype frequency distributions for HMGCR (rs5908, rs17238540, rs12916), LDLR (rs688), CYP7A1 (rs3808607), ABCB1 (rs1128503), and SLCO1B1 (rs4149056) genetic variants among healthy subjects of South Indian Tamil population. The South Indian Tamil population is a unique ethnic group in terms of genetic polymorphisms in the cholesterol and statin metabolic pathways.
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